Johnson & Johnson

JNJ - Johnson & JohnsonDividends

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding DateValue (U$)Frequency
8/25/2026
1,34
Quarterly
5/26/2026
1,34
Quarterly
2/24/2026
1,3
Quarterly
11/25/2025
1,3
Quarterly
8/26/2025
1,3
Quarterly
5/27/2025
1,3
Quarterly
2/18/2025
1,24
Quarterly
11/26/2024
1,24
Quarterly
8/27/2024
1,24
Quarterly
5/20/2024
1,24
Quarterly
2/16/2024
1,19
Quarterly
11/20/2023
1,19
Quarterly
8/25/2023
1,19
Quarterly
5/22/2023
1,19
Quarterly
2/17/2023
1,13
Quarterly
11/21/2022
1,13
Quarterly
1/15

The latest dividend from JNJ was $1.34 per share (ex-dividend 8/25/2026). The dividend yield over the last 12 months is 2%. Over the last 12 months there were 4 distributions, totalling $5.28 per share.